J Chem Inf Model - Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.

Tópicos

{ compound(1573) activ(1297) structur(1058) }
{ bind(1733) structur(1185) ligand(1036) }
{ model(3404) distribut(989) bayesian(671) }
{ assess(1506) score(1403) qualiti(1306) }
{ first(2504) two(1366) second(1323) }
{ analysi(2126) use(1163) compon(1037) }
{ method(1219) similar(1157) match(930) }
{ use(976) code(926) identifi(902) }
{ data(1714) softwar(1251) tool(1186) }
{ visual(1396) interact(850) tool(830) }
{ perform(1367) use(1326) method(1137) }
{ sequenc(1873) structur(1644) protein(1328) }
{ surgeri(1148) surgic(1085) robot(1054) }
{ error(1145) method(1030) estim(1020) }
{ method(1557) propos(1049) approach(1037) }
{ search(2224) databas(1162) retriev(909) }
{ studi(1410) differ(1259) use(1210) }
{ risk(3053) factor(974) diseas(938) }
{ model(3480) simul(1196) paramet(876) }
{ model(2656) set(1616) predict(1553) }
{ data(2317) use(1299) case(1017) }
{ group(2977) signific(1463) compar(1072) }
{ gene(2352) biolog(1181) express(1162) }
{ data(3008) multipl(1320) sourc(1022) }
{ activ(1138) subject(705) human(624) }
{ use(1733) differ(960) four(931) }
{ drug(1928) target(777) effect(648) }
{ result(1111) use(1088) new(759) }
{ activ(1452) weight(1219) physic(1104) }
{ method(1969) cluster(1462) data(1082) }
{ method(2212) result(1239) propos(1039) }
{ can(774) often(719) complex(702) }
{ imag(1947) propos(1133) code(1026) }
{ data(1737) use(1416) pattern(1282) }
{ inform(2794) health(2639) internet(1427) }
{ system(1976) rule(880) can(841) }
{ measur(2081) correl(1212) valu(896) }
{ imag(1057) registr(996) error(939) }
{ featur(3375) classif(2383) classifi(1994) }
{ imag(2830) propos(1344) filter(1198) }
{ network(2748) neural(1063) input(814) }
{ imag(2675) segment(2577) method(1081) }
{ patient(2315) diseas(1263) diabet(1191) }
{ take(945) account(800) differ(722) }
{ studi(2440) review(1878) systemat(933) }
{ motion(1329) object(1292) video(1091) }
{ treatment(1704) effect(941) patient(846) }
{ framework(1458) process(801) describ(734) }
{ problem(2511) optim(1539) algorithm(950) }
{ chang(1828) time(1643) increas(1301) }
{ learn(2355) train(1041) set(1003) }
{ concept(1167) ontolog(924) domain(897) }
{ clinic(1479) use(1117) guidelin(835) }
{ algorithm(1844) comput(1787) effici(935) }
{ extract(1171) text(1153) clinic(932) }
{ design(1359) user(1324) use(1319) }
{ control(1307) perform(991) simul(935) }
{ model(2220) cell(1177) simul(1124) }
{ care(1570) inform(1187) nurs(1089) }
{ general(901) number(790) one(736) }
{ method(984) reconstruct(947) comput(926) }
{ featur(1941) imag(1645) propos(1176) }
{ case(1353) use(1143) diagnosi(1136) }
{ howev(809) still(633) remain(590) }
{ data(3963) clinic(1234) research(1004) }
{ perform(999) metric(946) measur(919) }
{ research(1085) discuss(1038) issu(1018) }
{ system(1050) medic(1026) inform(1018) }
{ import(1318) role(1303) understand(862) }
{ model(2341) predict(2261) use(1141) }
{ studi(1119) effect(1106) posit(819) }
{ blood(1257) pressur(1144) flow(957) }
{ spatial(1525) area(1432) region(1030) }
{ record(1888) medic(1808) patient(1693) }
{ health(3367) inform(1360) care(1135) }
{ monitor(1329) mobil(1314) devic(1160) }
{ ehr(2073) health(1662) electron(1139) }
{ state(1844) use(1261) util(961) }
{ research(1218) medic(880) student(794) }
{ patient(2837) hospit(1953) medic(668) }
{ age(1611) year(1155) adult(843) }
{ medic(1828) order(1363) alert(1069) }
{ signal(2180) analysi(812) frequenc(800) }
{ cost(1906) reduc(1198) effect(832) }
{ sampl(1606) size(1419) use(1276) }
{ intervent(3218) particip(2042) group(1664) }
{ time(1939) patient(1703) rate(768) }
{ patient(1821) servic(1111) care(1106) }
{ use(2086) technolog(871) perceiv(783) }
{ can(981) present(881) function(850) }
{ health(1844) social(1437) communiti(874) }
{ structur(1116) can(940) graph(676) }
{ high(1669) rate(1365) level(1280) }
{ cancer(2502) breast(956) screen(824) }
{ implement(1333) system(1263) develop(1122) }
{ survey(1388) particip(1329) question(1065) }
{ estim(2440) model(1874) function(577) }
{ decis(3086) make(1611) patient(1517) }
{ process(1125) use(805) approach(778) }
{ detect(2391) sensit(1101) algorithm(908) }

Resumo

The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase (RdRP) is a crucial and unique component of the HCV RNA replication machinery and a validated target for drug discovery. Multiple crystal structures of NS5B inhibitor complexes have facilitated the identification of novel compound scaffolds through in silico analysis. With the goal of discovering new NS5B inhibitor leads, HCV NS5B crystal structures bound with inhibitors in the palm and thumb allosteric pockets in combination with ligands with known inhibitory potential were explored for a comparative pharmacophore analyses. The energy-based and 3D-QSAR-based pharmacophore models were validated using enrichment analysis, and the six models thus developed were employed for high-throughput virtual screening and docking to identify nonpeptidic leads. The hits derived at each stage were analyzed for diversity based on the six pharmacophore models, followed by molecular docking and filtering based on their interaction with amino acids in the NS5B allosteric pocket and 3D-QSAR predictions. The resulting 10 hits displaying diverse scaffold were then screened employing biochemical and cell-based NS5B and anti-HCV inhibition assays. Of these, two molecules H-5 and H-6 were the most promising, exhibiting IC50 values of 28.8 and 47.3 ?M against NS5B polymerase and anti-HCV inhibition of 96% and 86% at 50 ?M, respectively. The identified leads comprised of benzimidazole (H-5) and pyridine (H-6) scaffolds thus constitute prototypical molecules for further optimization and development as NS5B inhibitors.

Resumo Limpo

hepat c virus hcv nsb rnadepend rna polymeras rdrp crucial uniqu compon hcv rna replic machineri valid target drug discoveri multipl crystal structur nsb inhibitor complex facilit identif novel compound scaffold silico analysi goal discov new nsb inhibitor lead hcv nsb crystal structur bound inhibitor palm thumb alloster pocket combin ligand known inhibitori potenti explor compar pharmacophor analys energybas dqsarbas pharmacophor model valid use enrich analysi six model thus develop employ highthroughput virtual screen dock identifi nonpeptid lead hit deriv stage analyz divers base six pharmacophor model follow molecular dock filter base interact amino acid nsb alloster pocket dqsar predict result hit display divers scaffold screen employ biochem cellbas nsb antihcv inhibit assay two molecul h h promis exhibit ic valu m nsb polymeras antihcv inhibit m respect identifi lead compris benzimidazol h pyridin h scaffold thus constitut prototyp molecul optim develop nsb inhibitor

Resumos Similares

J Chem Inf Model - Identification of sumoylation activating enzyme 1 inhibitors by structure-based virtual screening. ( 0,921328551410638 )
J Chem Inf Model - Selection of in silico drug screening results for G-protein-coupled receptors by using universal active probes. ( 0,916604968952828 )
J Chem Inf Model - Discovery of novel checkpoint kinase 1 inhibitors by virtual screening based on multiple crystal structures. ( 0,910700314685973 )
J Chem Inf Model - Structure-based design and screen of novel inhibitors for class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae. ( 0,909112970760552 )
J Chem Inf Model - Virtual fragment screening: discovery of histamine H3 receptor ligands using ligand-based and protein-based molecular fingerprints. ( 0,907943931544969 )
J Chem Inf Model - Application of quantitative structure-activity relationship models of 5-HT1A receptor binding to virtual screening identifies novel and potent 5-HT1A ligands. ( 0,907534917225138 )
J Chem Inf Model - FINDSITE(comb): a threading/structure-based, proteomic-scale virtual ligand screening approach. ( 0,907469611724755 )
J Chem Inf Model - Molecular modeling of potential anticancer agents from African medicinal plants. ( 0,903325017507815 )
J Chem Inf Model - Docking ligands into flexible and solvated macromolecules. 7. Impact of protein flexibility and water molecules on docking-based virtual screening accuracy. ( 0,902685411053719 )
J Chem Inf Model - Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal. ( 0,900582353617434 )
J Chem Inf Model - SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition. ( 0,89832687570804 )
J Chem Inf Model - Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor. ( 0,898192764836476 )
J Chem Inf Model - Validation of the AmpC ?-lactamase binding site and identification of inhibitors with novel scaffolds. ( 0,896934466708751 )
J Chem Inf Model - Visualization and virtual screening of the chemical universe database GDB-17. ( 0,895023731719161 )
J Chem Inf Model - Identification of novel S-adenosyl-L-homocysteine hydrolase inhibitors through homology-model-based virtual screening, synthesis, and biological evaluation. ( 0,89436123076189 )
J Chem Inf Model - Enrichment of chemical libraries docked to protein conformational ensembles and application to aldehyde dehydrogenase 2. ( 0,89185574940849 )
J Chem Inf Model - Structure-based virtual screening approach for discovery of covalently bound ligands. ( 0,891125714390843 )
J Chem Inf Model - Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example. ( 0,891100816362731 )
J Chem Inf Model - Structure based design, synthesis, pharmacophore modeling, virtual screening, and molecular docking studies for identification of novel cyclophilin D inhibitors. ( 0,889490262636791 )
J Chem Inf Model - Virtual screening yields inhibitors of novel antifungal drug target, benzoate 4-monooxygenase. ( 0,888374852026737 )
J Chem Inf Model - Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model. ( 0,887598141419536 )
J Chem Inf Model - Structure-based fragment hopping for lead optimization using predocked fragment database. ( 0,885705257573605 )
J Chem Inf Model - Ligand and decoy sets for docking to G protein-coupled receptors. ( 0,884792146697258 )
J Chem Inf Model - Feasibility of using molecular docking-based virtual screening for searching dual target kinase inhibitors. ( 0,87990561910119 )
J Chem Inf Model - Identification of novel liver X receptor activators by structure-based modeling. ( 0,877032465198683 )
J Chem Inf Model - Identification of novel serotonin transporter compounds by virtual screening. ( 0,873528319005066 )
J Chem Inf Model - Discovery of a7-nicotinic receptor ligands by virtual screening of the chemical universe database GDB-13. ( 0,870077107360644 )
J Chem Inf Model - Polypharmacology directed compound data mining: identification of promiscuous chemotypes with different activity profiles and comparison to approved drugs. ( 0,868257539763909 )
J Chem Inf Model - Identification of 1,2,5-oxadiazoles as a new class of SENP2 inhibitors using structure based virtual screening. ( 0,866798204518476 )
J Chem Inf Model - Freely available conformer generation methods: how good are they? ( 0,865468106945348 )
J Chem Inf Model - Alignment-independent comparison of binding sites based on DrugScore potential fields encoded by 3D Zernike descriptors. ( 0,861650147632135 )
J Chem Inf Model - Virtual screening for ligands of the insect molting hormone receptor. ( 0,861549179737617 )
J Chem Inf Model - Discovery of new inhibitors of Mycobacterium tuberculosis InhA enzyme using virtual screening and a 3D-pharmacophore-based approach. ( 0,86120295903826 )
J Chem Inf Model - Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening. ( 0,861072821551025 )
J Chem Inf Model - How to improve docking accuracy of AutoDock4.2: a case study using different electrostatic potentials. ( 0,857788474770818 )
J Chem Inf Model - Development and evaluation of an integrated virtual screening strategy by combining molecular docking and pharmacophore searching based on multiple protein structures. ( 0,854122763699757 )
Sci Data - Quantum chemistry structures and properties of 134 kilo molecules. ( 0,853554981202156 )
J Chem Inf Model - Targeting dynamic pockets of HIV-1 protease by structure-based computational screening for allosteric inhibitors. ( 0,853203346248474 )
J Chem Inf Model - Effective screening strategy using ensembled pharmacophore models combined with cascade docking: application to p53-MDM2 interaction inhibitors. ( 0,85313979608685 )
J Chem Inf Model - Identification of sumoylation inhibitors targeting a predicted pocket in Ubc9. ( 0,851248017343915 )
J Chem Inf Model - Application of docking and QM/MM-GBSA rescoring to screen for novel Myt1 kinase inhibitors. ( 0,85121586281664 )
J Chem Inf Model - Pharmacophore-based virtual screening and experimental validation of novel inhibitors against cyanobacterial fructose-1,6-/sedoheptulose-1,7-bisphosphatase. ( 0,851213415229137 )
J Chem Inf Model - Detailed computational study of the active site of the hepatitis C viral RNA polymerase to aid novel drug design. ( 0,848678741536098 )
J Chem Inf Model - Ligand- and structure-based virtual screening for clathrodin-derived human voltage-gated sodium channel modulators. ( 0,84835094049542 )
J Chem Inf Model - Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification. ( 0,846650422525826 )
J Chem Inf Model - G-protein coupled receptors virtual screening using genetic algorithm focused chemical space. ( 0,846399905583206 )
J Chem Inf Model - Exploration of 3D activity cliffs on the basis of compound binding modes and comparison of 2D and 3D cliffs. ( 0,845450417545715 )
J Chem Inf Model - Automatic tailoring and transplanting: a practical method that makes virtual screening more useful. ( 0,844951334860574 )
J Chem Inf Model - De novo design of drug-like molecules by a fragment-based molecular evolutionary approach. ( 0,844900198519264 )
J Chem Inf Model - Identification of novel potential antibiotics against Staphylococcus using structure-based drug screening targeting dihydrofolate reductase. ( 0,8432124249507 )
J Chem Inf Model - Increasing the coverage of medicinal chemistry-relevant space in commercial fragments screening. ( 0,842393035316012 )
Comput. Biol. Med. - Computational identification of novel histone deacetylase inhibitors by docking based QSAR. ( 0,842278399855748 )
J Chem Inf Model - Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries. ( 0,841867540628293 )
J Chem Inf Model - Chemoisosterism in the proteome. ( 0,840903885166432 )
J Chem Inf Model - Novel mycosin protease MycP1 inhibitors identified by virtual screening and 4D fingerprints. ( 0,839990345999254 )
J Chem Inf Model - DiSCuS: an open platform for (not only) virtual screening results management. ( 0,839583788836815 )
J Chem Inf Model - Identification of compounds with potential antibacterial activity against Mycobacterium through structure-based drug screening. ( 0,83857733766744 )
J Chem Inf Model - Rapid scanning structure-activity relationships in combinatorial data sets: identification of activity switches. ( 0,837295731907181 )
J Chem Inf Model - Extended template-based modeling and evaluation method using consensus of binding mode of GPCRs for virtual screening. ( 0,835151763821343 )
J Chem Inf Model - Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library. ( 0,835028075053557 )
J Chem Inf Model - Hot spot analysis for driving the development of hits into leads in fragment-based drug discovery. ( 0,834946977120588 )
J Chem Inf Model - Novel method for pharmacophore analysis by examining the joint pharmacophore space. ( 0,834780331726287 )
J Chem Inf Model - Searching for recursively defined generic chemical patterns in nonenumerated fragment spaces. ( 0,834335499438181 )
J Chem Inf Model - Mining the ChEMBL database: an efficient chemoinformatics workflow for assembling an ion channel-focused screening library. ( 0,833983930948488 )
J Chem Inf Model - Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: discovery of amiodarone and bromocriptine inhibitory effects. ( 0,832639251038332 )
J Chem Inf Model - TIN-a combinatorial compound collection of synthetically feasible multicomponent synthesis products. ( 0,832377000510959 )
J Chem Inf Model - Automated recycling of chemistry for virtual screening and library design. ( 0,832329727133775 )
J Chem Inf Model - Identification of alternative binding sites for inhibitors of HIV-1 ribonuclease H through comparative analysis of virtual enrichment studies. ( 0,832110759963587 )
J Chem Inf Model - From activity cliffs to activity ridges: informative data structures for SAR analysis. ( 0,831881897848748 )
J Chem Inf Model - Discovery of a novel selective kappa-opioid receptor agonist using crystal structure-based virtual screening. ( 0,831797937184096 )
J Chem Inf Model - Investigation of the differences in activity between hydroxycycloalkyl N1 substituted pyrazole derivatives as inhibitors of B-Raf kinase by using docking, molecular dynamics, QM/MM, and fragment-based de novo design: study of binding mode of diastereomer compounds. ( 0,831780513454421 )
J Chem Inf Model - Compound optimization through data set-dependent chemical transformations. ( 0,831185676439892 )
J Chem Inf Model - How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space. ( 0,830385168155991 )
J Chem Inf Model - Identification of multitarget activity ridges in high-dimensional bioactivity spaces. ( 0,830348177737004 )
J Chem Inf Model - Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction. ( 0,829310488336865 )
J Chem Inf Model - In silico enzymatic synthesis of a 400,000 compound biochemical database for nontargeted metabolomics. ( 0,82910245788667 )
J Chem Inf Model - SimG: an alignment based method for evaluating the similarity of small molecules and binding sites. ( 0,826221712621905 )
J Chem Inf Model - Discovery of novel histamine H4 and serotonin transporter ligands using the topological feature tree descriptor. ( 0,826200388948301 )
J Chem Inf Model - Scaffold diversity of exemplified medicinal chemistry space. ( 0,826114433662498 )
J Chem Inf Model - Computer-aided structure-based design of multitarget leads for Alzheimer's disease. ( 0,825347613738427 )
J Chem Inf Model - Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17. ( 0,824658759788865 )
Curr Comput Aided Drug Des - Development of Chemical Compound Libraries for In Silico Drug Screening. ( 0,824565047474165 )
J Chem Inf Model - Visual characterization and diversity quantification of chemical libraries: 1. creation of delimited reference chemical subspaces. ( 0,820818853310313 )
J Chem Inf Model - QSAR classification model for antibacterial compounds and its use in virtual screening. ( 0,820637886286751 )
J Chem Inf Model - Identification of non-macrocyclic small molecule inhibitors against the NS3/4A serine protease of hepatitis C virus through in silico screening. ( 0,820222420902266 )
J Chem Inf Model - A new protocol for predicting novel GSK-3? ATP competitive inhibitors. ( 0,819018208028547 )
J Chem Inf Model - Multi-objective evolutionary design of adenosine receptor ligands. ( 0,818900832691709 )
J Chem Inf Model - Best of both worlds: on the complementarity of ligand-based and structure-based virtual screening. ( 0,817948367374369 )
J Chem Inf Model - Capturing structure-activity relationships from chemogenomic spaces. ( 0,817692092259944 )
J Chem Inf Model - Molecular modeling on pyrimidine-urea inhibitors of TNF-a production: an integrated approach using a combination of molecular docking, classification techniques, and 3D-QSAR CoMSIA. ( 0,817275741533911 )
J Chem Inf Model - Conditional probabilistic analysis for prediction of the activity landscape and relative compound activities. ( 0,816691240255156 )
J Chem Inf Model - Introduction of target cliffs as a concept to identify and describe complex molecular selectivity patterns. ( 0,815702733645977 )
J Chem Inf Model - Extending the activity cliff concept: structural categorization of activity cliffs and systematic identification of different types of cliffs in the ChEMBL database. ( 0,815671932808991 )
J Chem Inf Model - Target-independent prediction of drug synergies using only drug lipophilicity. ( 0,81499291532733 )
J Chem Inf Model - Combining horizontal and vertical substructure relationships in scaffold hierarchies for activity prediction. ( 0,813554536370156 )
J Chem Inf Model - Scanning structure-activity relationships with structure-activity similarity and related maps: from consensus activity cliffs to selectivity switches. ( 0,813294359075238 )
J Chem Inf Model - Identifying compound-target associations by combining bioactivity profile similarity search and public databases mining. ( 0,812782581908089 )
J Chem Inf Model - G protein- and agonist-bound serotonin 5-HT2A receptor model activated by steered molecular dynamics simulations. ( 0,811174358326782 )
J Chem Inf Model - Scaffold-focused virtual screening: prospective application to the discovery of TTK inhibitors. ( 0,810914140647687 )
J Chem Inf Model - Natural product-like virtual libraries: recursive atom-based enumeration. ( 0,810164869423896 )